We regularly answer frequently asked questions about life in the era of COVID-19. If you have a question you'd like us to consider for a future post, email us at goatsandsoda@npr.org with the subject ...

Pfizer said Wednesday that a booster of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective.

A “one-size-fits-all approach for scheduling COVID-19 booster shots” may not be the most effective, according to results of a new study done by researchers at the Yale School of Public Health and ...

According to a study of more than 5.5 million adults aged 50 years or older, vaccination with the bivalent BA.1 mRNA booster ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to get the full newsletter in your inbox, including answers to reader ...

NEW YORK -- Two encouraging studies suggest that people who recovered from COVID-19 had immune responses to the virus long after antibodies faded, even up to one year later. The findings may help put ...

Pfizer's and Moderna's omicron boosters reduced the risk of mild illness from the XBB family of subvariants compared to people who did not receive the shot, according to a study from the Centers for ...

How long does immunity last after an infection? Are rapid tests always accurate? How often is a booster in order? In this installment of our FAQ... We regularly answer frequently asked questions about ...